DL-allo-isoleucine is a non-proteinogenic stereoisomeric amino acid belonging to the aliphatic, branched-chain amino acid family, featuring a side chain with a secondary carbon bearing an additional methyl substituent. The molecule contains both an amino group and a carboxyl group, and its "allo" stereochemical relationship relative to the corresponding canonical isoleucine framework defines the spatial arrangement of the side-chain substituents; the "DL" designation indicates a racemic mixture of enantiomers. As a free amino acid, it is used as a defined building block for peptide and amino acid derivative synthesis and for structure-property studies where stereochemical effects on incorporation, conformational preferences, or analytical behavior are assessed.
DL-allo-isoleucine is a stereochemically defined allo-configuration isomer of isoleucine featuring a branched aliphatic side chain and the canonical amino acid functionality. The molecule contains a primary amino group and a carboxylic acid, enabling salt formation and standard amino acid coupling chemistry, while the chiral center(s) associated with the allo stereochemistry influence downstream stereochemical outcomes in derivatives and peptides. As a DL mixture, it presents both enantiomeric forms, which is relevant for racemic intermediate preparation, method development, and stereochemical screening. The side-chain structure supports derivatization via amide/ester formation and conversion to protected amino acid derivatives for controlled peptide assembly and subsequent functional transformations.
1. Peptide Synthesis
DL-allo-isoleucine is used in peptide building workflows where an isoleucine-like side chain participates in backbone assembly and side-chain steric patterning. The amino acid's carboxyl group can be activated for amide bond formation, while the amino functionality can be protected (for example, as an N-protected amino acid derivative) to enable selective coupling at the desired step. The allo stereochemical relationship relative to other isoleucine epimers can be leveraged during peptide analog construction to probe how stereochemical placement affects conformation and coupling outcomes. Racemic availability supports parallel synthesis and comparative studies of enantiomeric effects in peptide synthesis and peptidomimetic construction.
2. Amino Acid Derivatization
DL-allo-isoleucine serves as a substrate for amino acid derivatization strategies that convert the carboxylic acid into esters or activated intermediates and transform the amino group into protected or functionalized forms. The branched side chain can be carried through as a stable aliphatic motif during derivatization, while the amino and carboxyl groups enable downstream formation of amides, ureas, and peptide-like linkages. Derivative preparation can be tailored for solubility control via salt formation or esterification, supporting synthetic intermediate handling in fine chemical synthesis. Racemic composition can be applied to method development for stereoselective transformations, including routes that later resolve enantiomers or generate stereodefined products via chiral downstream steps.
3. Chiral Synthesis Screening
DL-allo-isoleucine is suitable for chiral synthesis screening and stereochemical route development because the allo stereocenter(s) and the DL racemate provide a defined starting stereochemical motif for evaluation. The amino acid's functional groups allow conversion into chiral auxiliary-bound or N-protected intermediates, enabling assessment of stereochemical outcomes in subsequent coupling, protection/deprotection, or side-chain functionalization steps. Racemic input supports process chemistry intermediate preparation where stereochemical selectivity can be introduced later using chiral catalysts, chiral resolving agents, or asymmetric derivatization strategies. The resulting stereochemical datasets can guide selection of protecting-group patterns and coupling conditions for producing enantiopure amino acid derivatives or stereodefined peptide building blocks.
4. Chemical Biology Probes
DL-allo-isoleucine can be applied in chemical biology research workflows that require amino acid-based handles for incorporation into peptides, peptidomimetics, or biomolecule-modifying scaffolds. The primary amino and carboxylic acid groups enable attachment of functional tags through amide coupling to linkers, affinity moieties, or reporter groups after conversion to protected amino acid derivatives. The branched aliphatic side chain can influence local hydrophobicity and conformational preferences, which may affect probe behavior when incorporated into recognition sequences or enzyme-interaction motifs. Racemic material can be used for initial probe design and structure-activity relationship studies, with later stereochemical refinement performed through resolution or asymmetric synthesis of specific enantiomers.
5. Pharmaceutical Intermediate Preparation
DL-allo-isoleucine is utilized as an amino acid intermediate in pharmaceutical and specialty chemical manufacturing contexts where amino acid-derived fragments are assembled into larger heteroatom-containing scaffolds. The carboxyl group supports activation to form amide linkages, while N-protection strategies enable controlled coupling in multistep synthetic sequences without undesired side reactions. Allo stereochemistry can be carried through as a structural element in peptidomimetic or amino acid-derived cores, supporting the synthesis of stereochemically specified analogs after downstream stereochemical control. Industrially, the racemic starting material can be integrated into process chemistry intermediate preparation, including routes that introduce stereodefined centers during later stages to meet specific synthetic targets for fine chemical production.
6. Analytical Research Standards
DL-allo-isoleucine is applicable to analytical research as a reference material for chromatographic and spectroscopic method development involving amino acid stereochemistry. The amino acid's well-defined functional groups facilitate derivatization to detectable derivatives, supporting enantiomer discrimination workflows when combined with chiral derivatization reagents or chiral stationary phases. Racemic composition helps establish baseline retention and signal behavior for allo-isoleucine epimeric and enantiomeric mixtures, which is useful for quality control of amino acid intermediates and peptide hydrolysate analyses. The compound thereby functions as an amino acid chemistry benchmark for stereochemical verification and for monitoring downstream conversion to protected amino acid derivatives or peptide building blocks.
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More